The results obtained suggest that the constructed VLPs do not appear to be cytotoxic to either breast cancer cells that lack HER2 overexpression and breast cancers that display HER2 overexpression, as there was no substantial decrease in cell viability. This evidence concerns the gene ERBB2 and breast carcinoma.